116 related articles for article (PubMed ID: 37366294)
1. Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.
Zhou JY; Wang S; Yuan HL; Xu YJ; Huang XB; Gao SJ; Zhang YC; Zhou F; Liu Y; Song XM; Cai Y; Liu XL; Luo Y; Yang LX; Yang JM; Wang LB; Li YH; Huang R; Wang SQ; Zhou M; Dong YJ; Wang Q; Zhang X; Feng YM; Du X; Ling W; Zhu H; Zhu ZM; Chen XL; Wang SY; Meng FK; Bi KH; Huang N; Jiang M; Niu T; Ji J; Wan DM; Bian ZL; Chen Y; Liu L; Yan XQ; Yang X; Yi H; Wei XD; Li X; Cheng Q; Yuan CL; Wang W; Zhou YH; Ye BD; Ding J; Wu YJ; Huang QS; Zhu XL; Chen YH; He Y; Wang FR; Zhang YY; Mo XD; Han W; Wang JZ; Wang Y; Chen H; Zhao XY; Chang YJ; Liu KY; Huang XJ; Zhang XH
Am J Hematol; 2023 Sep; 98(9):1394-1406. PubMed ID: 37366294
[TBL] [Abstract][Full Text] [Related]
2. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study.
Itonaga H; Iwanaga M; Aoki K; Aoki J; Ishiyama K; Ishikawa T; Sakura T; Fukuda T; Najima Y; Yujiri T; Mori T; Kurokawa M; Nawa Y; Uchida N; Morishita Y; Hashimoto H; Eto T; Hirokawa M; Morishima Y; Nagamura-Inoue T; Atsuta Y; Miyazaki Y
Leuk Res; 2016 Feb; 41():48-55. PubMed ID: 26754557
[TBL] [Abstract][Full Text] [Related]
3. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia].
Zhang XH; Zhou JY
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):18-21. PubMed ID: 38527833
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
[TBL] [Abstract][Full Text] [Related]
6. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Robin M; de Wreede LC; Padron E; Bakunina K; Fenaux P; Koster L; Nazha A; Beelen DW; Rampal RK; Sockel K; Komrokji RS; Gagelmann N; Eikema DJ; Radujkovic A; Finke J; Potter V; Killick SB; Legrand F; Solary E; Broom A; Garcia-Manero G; Rizzoli V; Hayden P; Patnaik MM; Onida F; Yakoub-Agha I; Itzykson R
Blood; 2022 Sep; 140(12):1408-1418. PubMed ID: 35667047
[TBL] [Abstract][Full Text] [Related]
7. [Impact of splenomegaly on outcomes of allogeneic hematopoietic stem cell transplantation in patients with chronic myelomonocytic leukemia].
Zhao C; Huang XJ; Zhao XS; Wang Y; Yan CH; Xu LP; Zhang XH; Liu KY; Sun YQ
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):308-312. PubMed ID: 32447935
[No Abstract] [Full Text] [Related]
8. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
[TBL] [Abstract][Full Text] [Related]
9. [Incidence and clinical significance of platelet transfusion refractoriness after allogeneic hematopoietic stem cell transplantation in patients with chronic myelomonocytic leukemia].
Zhao C; Zhao XS; Wang Y; Yan CH; Xu LP; Zhang XH; Liu KY; Huang XJ; Sun YQ
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):738-744. PubMed ID: 36709167
[No Abstract] [Full Text] [Related]
10. [Clinical Analysis on Treatment of Chronic Myelomonocytic Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation].
Wang T; Li WY; Qi XF; Zhang R; Jing ZM; Qiu HY; Han Y; Ma X; Fu CC; Tang XW; Chen SN; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1667-72. PubMed ID: 26708891
[TBL] [Abstract][Full Text] [Related]
11. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
[TBL] [Abstract][Full Text] [Related]
13. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
14. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Hosoba S; Waller EK; Shenvi N; Graiser M; Easley KA; Al-Kadhimi Z; Andoh A; Antun AG; Barclay S; Josephson CD; Koff JL; Khoury HJ; Langston AA; Zimring JC; Roback JD; Giver CR
Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Wedge E; Hansen JW; Dybedal I; Creignou M; Ejerblad E; Lorenz F; Werlenius O; Ungerstedt J; Holm MS; Nilsson L; Kittang AO; Antunovic P; Rohon P; Andersen MK; Papaemmanuil E; Bernard E; Jädersten M; Hellström-Lindberg E; Grønbæk K; Ljungman P; Friis LS
Transplant Cell Ther; 2021 Dec; 27(12):991.e1-991.e9. PubMed ID: 34500124
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies.
Deng RX; Wu YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Am J Hematol; 2021 Nov; 96(11):1407-1419. PubMed ID: 34350623
[TBL] [Abstract][Full Text] [Related]
17. European Group for Blood and Marrow Transplantation score correlates with outcomes of older patients undergoing allogeneic hematopoietic stem cell transplantation.
Chien SH; Liu YC; Liu CJ; Ko PS; Wang HY; Hsiao LT; Lin JS; Chiou TJ; Liu CY; Gau JP
J Chin Med Assoc; 2020 Mar; 83(3):238-244. PubMed ID: 31904659
[TBL] [Abstract][Full Text] [Related]
18. Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation.
Pan X; Gao M; Sun Y; Zhou Y; Wang K; Wang Y; Xu L; Zhang X; Huang X; Zhao XS
Int J Lab Hematol; 2022 Jun; 44(3):510-517. PubMed ID: 35061336
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
Liu HD; Ahn KW; Hu ZH; Hamadani M; Nishihori T; Wirk B; Beitinjaneh A; Rizzieri D; Grunwald MR; Sabloff M; Olsson RF; Bajel A; Bredeson C; Daly A; Inamoto Y; Majhail N; Saad A; Gupta V; Gerds A; Malone A; Tallman M; Reshef R; Marks DI; Copelan E; Gergis U; Savoie ML; Ustun C; Litzow MR; Cahn JY; Kindwall-Keller T; Akpek G; Savani BN; Aljurf M; Rowe JM; Wiernik PH; Hsu JW; Cortes J; Kalaycio M; Maziarz R; Sobecks R; Popat U; Alyea E; Saber W
Biol Blood Marrow Transplant; 2017 May; 23(5):767-775. PubMed ID: 28115276
[TBL] [Abstract][Full Text] [Related]
20. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]